SEC Form 4 · accession 0001209191-15-085622
Zosano Pharma Corp · ZSAN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laxmi Peri
Officer — Sr. Vice President, Operations
Period of report
Dec 15, 2015
Accepted (ET)
Dec 16, 2015 · 6:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001587221
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2,F1 | $9.29 | Dec 15, 2015 | D | 40,000 | D | — | May 22, 2025 | Common Stock | 40,000 | 0 | D |
| Employee Stock Option (right to buy)F2,F3 | $2.26 | Dec 15, 2015 | A | 40,000 | A | — | Dec 15, 2025 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1The option provided for 25% of the total number of shares underlying the stock option to vest on April 27, 2016, and the remaining underlying shares to vest in equal monthly installments over the following three-year period.
- F2On December 15, 2015, the issuer canceled, pursuant to the issuer's option exchange program, an option for 40,000 shares of ZSAN common stock granted to the reporting person on May 22, 2015. In exchange, the reporting person received a replacement option, for 40,000 shares, having an exercise price of $2.26 per share.
- F325% of the total number of shares underlying the stock option vest on December 15, 2016, and the remaining underlying shares vest in equal monthly installments over the following three-year period.